Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
Send hemochron signature elite competency test via email, link, or fax. You can also download it, export it or print it out.
How to use or fill out hemochron signature elite with our platform
Ease of Setup
DocHub User Ratings on G2
Ease of Use
DocHub User Ratings on G2
Click ‘Get Form’ to open the hemochron signature elite in the editor.
Begin by entering the YEAR and MONTH at the top of the form. This helps in organizing your records effectively.
Fill in the INSTRUMENT ID # and SITE fields to identify the specific equipment and location used for testing.
For each day, record the TIME and results for both Liquid Normal QC and Liquid Abnormal QC. Ensure you follow the specified ranges for accurate results.
Document any CLEAN, ELECTRONIC QC, and TEMP readings as required every 8 hours, ensuring compliance with maintenance protocols.
In the COMMENTS & REVIEW section, note any corrective actions taken along with their corresponding IDs and dates for future reference.
Start using our platform today to streamline your hemochron signature elite documentation process for free!
Fill out hemochron signature elite online It's free
We've got more versions of the hemochron signature elite form. Select the right hemochron signature elite version from the list and start editing it straight away!
The activated clotting time (ACT) is measured with the Hemochron Response instruments. The ACT test is commonly used for anticoagulation monitoring during bypass surgery, neonatal Extracorporeal Membrane Oxygenation (ECMO), hemodialysis, radio frequency ablation, and critical care.
What is an ACT LR blood test?
The activated clotting time (ACT) is a test that is used primarily to monitor high doses of unfractionated (standard) therapy. is a drug that inhibits blood clotting (anticoagulant) and is usually given through a vein (intravenously, IV), by injection or continuous infusion.
What does Hemochron Signature Elite use for?
INTENDED USE The Hemochron Signature Elite Whole Blood Microcoagulation System is a battery-operated, hand-held instrument that performs individual point-of-care coagulation tests on fresh or citrated whole blood.
What is the difference between Hemochron and Hemotec?
The Hemochron requires a clot to form that breaks the mag- net in the tube away from a detector in the machine. This may require a stronger clot than is necessary for the Hemotec device to signal a clot. The Hemotec may be more sensitive to clot formation and detect a clot before the Hemochron would.
What is the Hemochron Signature ACT?
For rapid whole blood testing, Hemochron Signature Elite system standardizes ACT+, ACT-LR, PT and APTT testing at the point of care. Rapid, accurate and reproducible results, for patient management decisions in acute care settings, from the Cardiovascular Operating Room to the Cardiac Catherization Lab.
The Hemochron Signature Elite utilizes a mechanical endpoint clotting mechanism in which testing occurs within the disposable ACT-LR cuvette. Following whole blood sample introduction, the instrument measures 15 microliters of blood and automatically moves the sample into the test channel within the ACT-LR cuvette.
What is the difference between ACT LR and ACT+?
According to the manufacturer, the Hemochron ACT-LR cuvette is designated for concentrations of 0 to 2.5 IU/mL, while the optimal concentration range for the ACT+ cartridge is 1 to 6 IU/mL. We hypothesized that at low to moderate concentrations, the ACT-LR is more reliable than the ACT+.
Related links
Transition from Hemochron Response to
by GS Matte 2019 Cited by 16 The Hemochron Signature Elite device uses a combination of silica, phospholipid, and kaolin as activators and precisely mixes the activators with blood
Cookie consent notice
This site uses cookies to enhance site navigation and personalize your experience.
By using this site you agree to our use of cookies as described in our Privacy Notice.
You can modify your selections by visiting our Cookie and Advertising Notice.
